Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in PLoS Pathog

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    June 2018
  1. KITAMURA K, Que L, Shimadu M, Koura M, et al
    Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
    PLoS Pathog. 2018;14:e1007124.
    PubMed     Text format     Abstract available


    May 2018
  2. LIU K, Luckenbaugh L, Ning X, Xi J, et al
    Multiple roles of core protein linker in hepatitis B virus replication.
    PLoS Pathog. 2018;14:e1007085.
    PubMed     Text format     Abstract available


  3. LIANG Y, Cao X, Ding Q, Zhao Y, et al
    Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway.
    PLoS Pathog. 2018;14:e1007075.
    PubMed     Text format     Abstract available


    March 2018
  4. SEKHAR V, Pollicino T, Diaz G, Engle RE, et al
    Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    PLoS Pathog. 2018;14:e1006916.
    PubMed     Text format     Abstract available


  5. DOUAM F, Fusil F, Enguehard M, Dib L, et al
    A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.
    PLoS Pathog. 2018;14:e1006908.
    PubMed     Text format     Abstract available


    February 2018
  6. BOUKADIDA C, Fritz M, Blumen B, Fogeron ML, et al
    NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities.
    PLoS Pathog. 2018;14:e1006863.
    PubMed     Text format     Abstract available


    January 2018
  7. YIN C, Goonawardane N, Stewart H, Harris M, et al
    A role for domain I of the hepatitis C virus NS5A protein in virus assembly.
    PLoS Pathog. 2018;14:e1006834.
    PubMed     Text format     Abstract available


    December 2017
  8. DENOLLY S, Mialon C, Bourlet T, Amirache F, et al
    The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.
    PLoS Pathog. 2017;13:e1006774.
    PubMed     Text format     Abstract available


  9. GOPAL R, Jackson K, Tzarum N, Kong L, et al
    Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis.
    PLoS Pathog. 2017;13:e1006735.
    PubMed     Text format     Abstract available


    October 2017
  10. YU Y, Scheel TKH, Luna JM, Chung H, et al
    miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence.
    PLoS Pathog. 2017;13:e1006694.
    PubMed     Text format     Abstract available


  11. KUMTHIP K, Yang D, Li NL, Zhang Y, et al
    Pivotal role for the ESCRT-II complex subunit EAP30/SNF8 in IRF3-dependent innate antiviral defense.
    PLoS Pathog. 2017;13:e1006713.
    PubMed     Text format     Abstract available


    September 2017
  12. WANG L, Kim JY, Liu HM, Lai MMC, et al
    HCV-induced autophagosomes are generated via homotypic fusion of phagophores that mediate HCV RNA replication.
    PLoS Pathog. 2017;13:e1006609.
    PubMed     Text format     Abstract available


  13. GUO F, Zhao Q, Sheraz M, Cheng J, et al
    HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.
    PLoS Pathog. 2017;13:e1006658.
    PubMed     Text format     Abstract available


    June 2017
  14. BENZINE T, Brandt R, Lovell WC, Yamane D, et al
    NS5A inhibitors unmask differences in functional replicase complex half-life between different hepatitis C virus strains.
    PLoS Pathog. 2017;13:e1006343.
    PubMed     Text format     Abstract available


    May 2017
  15. YIN X, Li X, Ambardekar C, Hu Z, et al
    Hepatitis E virus persists in the presence of a type III interferon response.
    PLoS Pathog. 2017;13:e1006417.
    PubMed     Text format     Abstract available


  16. ONO C, Fukuhara T, Motooka D, Nakamura S, et al
    Characterization of miR-122-independent propagation of HCV.
    PLoS Pathog. 2017;13:e1006374.
    PubMed     Text format     Abstract available


    April 2017
  17. LIU Y, Nie H, Mao R, Mitra B, et al
    Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA.
    PLoS Pathog. 2017;13:e1006296.
    PubMed     Text format     Abstract available


  18. ZHANG X, Zhu C, Wang T, Jiang H, et al
    GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
    PLoS Pathog. 2017;13:e1006321.
    PubMed     Text format     Abstract available


    February 2017
  19. EL-DIWANY R, Cohen VJ, Mankowski MC, Wasilewski LN, et al
    Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1.
    PLoS Pathog. 2017;13:e1006235.
    PubMed     Text format     Abstract available


  20. BHATTARAI N, McLinden JH, Xiang J, Mathahs MM, et al
    Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
    PLoS Pathog. 2017;13:e1006232.
    PubMed     Text format     Abstract available


  21. MCFADDEN VC, Shalaby RE, Iram S, Oropeza CE, et al
    Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylation.
    PLoS Pathog. 2017;13:e1006239.
    PubMed     Text format     Abstract available


  22. VELAZQUEZ-MOCTEZUMA R, Law M, Bukh J, Prentoe J, et al
    Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.
    PLoS Pathog. 2017;13:e1006214.
    PubMed     Text format     Abstract available


  23. ABDEL-HAKEEM MS, Boisvert M, Bruneau J, Soudeyns H, et al
    Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearance.
    PLoS Pathog. 2017;13:e1006191.
    PubMed     Text format     Abstract available


    October 2016
  24. QI Y, Gao Z, Xu G, Peng B, et al
    DNA Polymerase kappa Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    PLoS Pathog. 2016;12:e1005893.
    PubMed     Text format     Abstract available


    September 2016
  25. RAGHWANI J, Rose R, Sheridan I, Lemey P, et al
    Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.
    PLoS Pathog. 2016;12:e1005894.
    PubMed     Text format     Abstract available


    August 2016
  26. MENG XJ
    Expanding Host Range and Cross-Species Infection of Hepatitis E Virus.
    PLoS Pathog. 2016;12:e1005695.
    PubMed     Text format    


  27. GILL US, Peppa D, Micco L, Singh HD, et al
    Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.
    PLoS Pathog. 2016;12:e1005788.
    PubMed     Text format     Abstract available


  28. CHEN C, Wang JC, Pierson EE, Keifer DZ, et al
    Importin beta Can Bind Hepatitis B Virus Core Protein and Empty Core-Like Particles and Induce Structural Changes.
    PLoS Pathog. 2016;12:e1005802.
    PubMed     Text format     Abstract available


    July 2016
  29. PFAENDER S, Grabski E, Detje CN, Riebesehl N, et al
    Hepatitis C Virus Stimulates Murine CD8alpha-Like Dendritic Cells to Produce Type I Interferon in a TRIF-Dependent Manner.
    PLoS Pathog. 2016;12:e1005736.
    PubMed     Text format     Abstract available


  30. KIM GW, Lee SH, Cho H, Kim M, et al
    Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2.
    PLoS Pathog. 2016;12:e1005714.
    PubMed     Text format     Abstract available


    June 2016
  31. KHAN M, Syed GH, Kim SJ, Siddiqui A, et al
    Hepatitis B Virus-Induced Parkin-Dependent Recruitment of Linear Ubiquitin Assembly Complex (LUBAC) to Mitochondria and Attenuation of Innate Immunity.
    PLoS Pathog. 2016;12:e1005693.
    PubMed     Text format     Abstract available


  32. FREEMAN ZT, Cox AL
    Lessons from Nature: Understanding Immunity to HCV to Guide Vaccine Design.
    PLoS Pathog. 2016;12:e1005632.
    PubMed     Text format    


    May 2016
  33. YAMAMOTO S, Fukuhara T, Ono C, Uemura K, et al
    Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.
    PLoS Pathog. 2016;12:e1005610.
    PubMed     Text format     Abstract available


    April 2016
  34. NAIR VP, Anang S, Subramani C, Madhvi A, et al
    Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus.
    PLoS Pathog. 2016;12:e1005521.
    PubMed     Text format     Abstract available


  35. VIEYRES G, Welsch K, Gerold G, Gentzsch J, et al
    ABHD5/CGI-58, the Chanarin-Dorfman Syndrome Protein, Mobilises Lipid Stores for Hepatitis C Virus Production.
    PLoS Pathog. 2016;12:e1005568.
    PubMed     Text format     Abstract available


    March 2016
  36. FLETCHER SP, Chin DJ, Gruenbaum L, Bitter H, et al
    Correction: Intrahepatic Transcriptional Signature Associated with Response to Interferon-alpha Treatment in the Woodchuck Model of Chronic Hepatitis B.
    PLoS Pathog. 2016;12:e1005541.
    PubMed     Text format     Abstract available


    February 2016
  37. NEUFELDT CJ, Joyce MA, Van Buuren N, Levin A, et al
    The Hepatitis C Virus-Induced Membranous Web and Associated Nuclear Transport Machinery Limit Access of Pattern Recognition Receptors to Viral Replication Sites.
    PLoS Pathog. 2016;12:e1005428.
    PubMed     Text format     Abstract available


  38. LAMONTAGNE J, Mell JC, Bouchard MJ
    Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression.
    PLoS Pathog. 2016;12:e1005438.
    PubMed     Text format     Abstract available


  39. SHI G, Ando T, Suzuki R, Matsuda M, et al
    Involvement of the 3' Untranslated Region in Encapsidation of the Hepatitis C Virus.
    PLoS Pathog. 2016;12:e1005441.
    PubMed     Text format     Abstract available



  40. Correction: The NLRP3 Inflammasome and IL-1beta Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis.
    PLoS Pathog. 2016;12:e1005406.
    PubMed     Text format     Abstract available


    January 2016

  41. Correction: Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection.
    PLoS Pathog. 2016;12:e1005386.
    PubMed     Text format     Abstract available


  42. ZAYAS M, Long G, Madan V, Bartenschlager R, et al
    Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A.
    PLoS Pathog. 2016;12:e1005376.
    PubMed     Text format     Abstract available


  43. ISKEN O, Langerwisch U, Jirasko V, Rehders D, et al
    Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication.
    PLoS Pathog. 2016;12:e1005394.
    PubMed     Text format     Abstract available


    December 2015
  44. BERG MG, Lee D, Coller K, Frankel M, et al
    Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection.
    PLoS Pathog. 2015;11:e1005325.
    PubMed     Text format     Abstract available


    November 2015
  45. BENDER S, Reuter A, Eberle F, Einhorn E, et al
    Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
    PLoS Pathog. 2015;11:e1005264.
    PubMed     Text format     Abstract available


  46. SCULL MA, Schneider WM, Flatley BR, Hayden R, et al
    The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production.
    PLoS Pathog. 2015;11:e1005297.
    PubMed     Text format     Abstract available


    October 2015
  47. GUPTA PK, Godec J, Wolski D, Adland E, et al
    CD39 Expression Identifies Terminally Exhausted CD8+ T Cells.
    PLoS Pathog. 2015;11:e1005177.
    PubMed     Text format     Abstract available


    September 2014
  48. VIGANO S, Banga R, Bellanger F, Pellaton C, et al
    CD160-Associated CD8 T-Cell Functional Impairment Is Independent of PD-1 Expression.
    PLoS Pathog. 2014;10:e1004380.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: